A common side effect of semaglutide is constipation, which can be uncomfortable and affect overall health
Assessment of the outcomes following the intervention, consumption of UPFs, has yielded inconsistent findings
Some practitioners recommend copper peptides after microneedling, laser treatments, or chemical peels to support faster healing
But for someone whose oncology team is also weighing post-treatment cardiovascular risk, the wider evidence base on semaglutide is reassuring
Identifying potential alternative medications, assessment of pancreatitis risk factors, and careful monitoring, are all important tenets in addressing GLP-1 agonists and pancreatitis
For information on recommended timing of when to stop GLP1-RAs prior to pregnancy please see Glucagon-like peptide-1 receptor agonists during pregnancy and lactation